Insider · CIK 0001244828

MANCHESTER KEITH S

Reports to the SEC for 4 companies · LONDON

sec.gov

Transactions

Companies

Filings

CIK

0001244828

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2026-09-16	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+10.5K sh	—	—	10,531
2026-09-16	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+5,054 sh	—	—	1,753,457
2026-06-30	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−12.4K sh	$35.28	−$437K	13,689,166
2026-06-30	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−200K sh	$35.45	−$7.09M	1,748,403
2026-06-29	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−200K sh	$34.44	−$6.89M	14,301,546
2026-06-29	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−600K sh	$34.59	−$20.8M	13,701,546
2026-06-26	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−325K sh	$34.07	−$11.1M	14,501,546
2026-06-26	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−301K sh	$33.92	−$10.2M	14,826,546
2026-02-13	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−151K sh	$26.49	−$3.99M	15,352,329
2026-02-13	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−225K sh	$26.50	−$5.96M	15,127,329
2026-02-12	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−275K sh	$26.76	−$7.36M	15,503,113
2026-02-12	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−150K sh	$26.72	−$4.01M	15,778,113
2026-02-11	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−425K sh	$26.67	−$11.3M	15,928,113
2025-12-17	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−433K sh	$23.05	−$9.97M	16,697,727
2025-12-17	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−155K sh	$23.02	−$3.57M	16,542,651
2025-12-17	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−190K sh	$23.17	−$4.39M	16,353,113
2025-12-16	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−642K sh	$23.08	−$14.8M	17,130,445
2025-12-16	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−275K sh	$22.93	−$6.31M	17,772,727
2025-11-19	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−850K sh	$20.25	−$17.2M	18,497,727
2025-11-19	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−125K sh	$20.16	−$2.52M	18,222,727
2025-11-19	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−175K sh	$20.24	−$3.54M	18,047,727
2025-11-19	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−150K sh	$20.20	−$3.03M	18,347,727
2025-09-10	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+33.7K sh	—	—	33,726
2025-09-10	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+14.5K sh	—	—	1,948,403
2025-06-25	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−3.18M sh	—	—	19,347,727
2025-06-25	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−1.17M sh	—	—	1,592,480
2025-06-25	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−6.84M sh	—	—	0
2025-06-25	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−6.21M sh	—	—	8,441,428
2024-09-25	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−135K sh	$11.77	−$1.59M	1,277,178
2024-09-24	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−368K sh	$11.63	−$4.28M	1,412,126
2024-09-10	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+27.9K sh	—	—	27,894
2024-09-10	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+16.4K sh	—	—	1,780,178
2024-08-14	ABUSArbutus Biopharma CorpS Sale	Director	SSale	−8,846 sh	$3.69	−$32.6K	46,069
2024-08-14	ABUSArbutus Biopharma CorpM Exercise/Conversion	Director	MExercise/Conversion	+54.9K sh	$0.56	+$30.8K	54,915
2024-08-14	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)M Exercise/Conversion	Director	MExercise/Conversion	−54.9K sh	—	—	0
2024-05-23	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director	AAward	+67K sh	—	—	67,000
2024-03-07	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−2.26M sh	—	—	2,763,126
2024-03-07	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−5.59M sh	—	—	6,837,266
2024-03-07	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−11.3M sh	—	—	23,105,358
2024-03-07	ROIVRoivant Sciences Ltd.J Other	Director	JOther	−11.1M sh	—	—	14,646,796
2023-09-28	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−1.1M sh	$11.55	−$12.8M	12,431,330
2023-09-28	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−446K sh	$11.55	−$5.16M	5,023,787
2023-09-28	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−2.29M sh	$11.55	−$26.4M	25,724,561
2023-09-28	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−3.06M sh	$11.55	−$35.3M	34,430,591
2023-09-12	ROIVRoivant Sciences Ltd.A Award	Director	AAward	+17.8K sh	—	—	69,967
2023-09-12	ROIVRoivant Sciences Ltd. · Stock Option (Right to Buy)A Award	Director	AAward	+26.6K sh	—	—	26,595
2023-05-24	ABUSArbutus Biopharma Corp · Stock Option (Right to Buy)A Award	Director	AAward	+55K sh	—	—	55,000
2022-11-10	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−146K sh	$4.75	−$694K	5,470,181
2022-11-10	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−1.09M sh	$4.75	−$5.19M	37,489,959
2022-11-10	ROIVRoivant Sciences Ltd.S Sale	Director	SSale	−372K sh	$4.75	−$1.77M	13,535,929

Recent filings

Accepted (ET)
Sep 184
MANCHESTER KEITH S0001140361-26-037158
SEC(opens sec.gov)
Jun 304
MANCHESTER KEITH S0001193125-26-291172
SEC(opens sec.gov)
Feb 134
MANCHESTER KEITH S0001193125-26-052130
SEC(opens sec.gov)
Dec 184
MANCHESTER KEITH S0001193125-25-325355
SEC(opens sec.gov)
Nov 214
MANCHESTER KEITH S0001193125-25-291734
SEC(opens sec.gov)

Companies

Address

C/O ROIVANT SCIENCES LTD. 7TH FLOOR, 50 BROADWAY

LONDON, SW1H 0DB